UAB "Caerus Biotechnologies" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 1,110,464 |
| 352,528 |
| 226,238 |
| -226,238 |
| -71,822 |
| 46.16 |
| -20.37 |
| -233,141 |
| 1,069,278 |
| 233,254 |
| 662,738 |
| 2023 |
|---|
| 1,116,963 |
| 450,388 |
| 22,784 |
| 20,628 |
| 8,318 |
| 66.80 |
| 1.85 |
| -212,513 |
| 1,245,813 |
| 109,111 |
| 946,558 |
| 2024 |
|---|
| 1,039,193 |
| 346,398 |
| 66,823 |
| 63,419 |
| 21,140 |
| 70.09 |
| 6.10 |
| -149,094 |
| 1,319,331 |
| 11,723 |
| 1,163,221 |
Register and
explore Okredo data| 2024 |
|---|
| 1,039,193 |
| 346,398 |
| 66,823 |
| 63,419 |
| 21,140 |
| 70.09 |
| 6.10 |
| -149,094 |
| 1,319,331 |
| 11,723 |
| 1,163,221 |
Register and
explore Okredo data2024
Turnover (€)
1,039,193 €
-7 % *
Sales per employee (€)
346,398 €-23 % *
Profit before tax (€)
66,823 €
193 % *
Net Profit (€)
63,419 €207 % *
Profit per employee (€)
21,140 €154 % *
Total profitability (%)
70.09 %4.93 % *
Net profitability (%)
6.10 %229.73 % *
Equity (€)
-149,094 €30 % *
Amounts Payable And Liabilities (€)
1,319,331 €
6 % *
Non-current Assets (€)
11,723 €
-89 % *
CurrentAssets (€)
1,163,221 €23 % *